Non-Invasive Measurement of Cerebral Oxygen Metabolism in the Mouse Brain by Ultra-High Field 17O MR Spectroscopy

To assess cerebral energetics in transgenic mouse models of neurologic disease, a robust, efficient, and practical method for quantification of cerebral oxygen consumption is needed. 17O magnetic resonance spectroscopy (MRS) has been validated to measure cerebral metabolic rate of oxygen (CMRO2) in the rat brain; however, mice present unique challenges because of their small size. We show that CMRO2 measurements with 17O MRS in the mouse brain are highly reproducible using 16.4 Tesla and a newly designed oxygen delivery system. The method can be utilized to measure mitochondrial function in mice quickly and repeatedly, without oral intubation, and has numerous potential applications to study cerebral energetics.

[1]  Yi Zhang,et al.  Tightly coupled brain activity and cerebral ATP metabolic rate , 2008, Proceedings of the National Academy of Sciences.

[2]  Kamil Ugurbil,et al.  Simplified Methods for Calculating Cerebral Metabolic Rate of Oxygen Based on 17O Magnetic Resonance Spectroscopic Imaging Measurement during a Short 17O2 Inhalation , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[3]  R. Price,et al.  A novel method for endotracheal intubation of mice and rats used in imaging studies. , 2005, Contemporary topics in laboratory animal science.

[4]  M. Mintun,et al.  Brain oxygen utilization measured with O-15 radiotracers and positron emission tomography. , 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  Nanyin Zhang,et al.  New Insights into Central Roles of Cerebral Oxygen Metabolism in the Resting and Stimulus-Evoked Brain , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[6]  Yi Zhang,et al.  In vitro and in vivo studies of 17O NMR sensitivity at 9.4 and 16.4 T , 2013, Magnetic resonance in medicine.

[7]  M. Beal,et al.  Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases , 2006, Nature.

[8]  C. Shaw,et al.  Lithium Therapy Improves Neurological Function and Hippocampal Dendritic Arborization in a Spinocerebellar Ataxia Type 1 Mouse Model , 2007, PLoS Medicine.

[9]  O. Andreassen,et al.  Creatine Increases Survival and Delays Motor Symptoms in a Transgenic Animal Model of Huntington's Disease , 2001, Neurobiology of Disease.

[10]  Yi Zhang,et al.  Noninvasive and Three-Dimensional Imaging of CMRO2 in Rats at 9.4 T: Reproducibility Test and Normothermia/Hypothermia Comparison Study , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[11]  Wei Chen,et al.  Simultaneous and noninvasive imaging of cerebral oxygen metabolic rate, blood flow and oxygen extraction fraction in stroke mice , 2013, NeuroImage.

[12]  O. Andreassen,et al.  Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease. , 2001, Neurobiology of disease.

[13]  Michael J Leach,et al.  Longitudinal , 2015, The Medical journal of Australia.

[14]  E. Duchesnay,et al.  Longitudinal brain metabolic changes from amnestic Mild Cognitive Impairment to Alzheimer's disease , 2009, NeuroImage.

[15]  Yi Zhang,et al.  In vivo 17O NMR approaches for brain study at high field , 2005, NMR in biomedicine.

[16]  Rolf Gruetter,et al.  Review Article Localized in vivo 13 C NMR spectroscopy of the brain , 2003 .